A comparison of hepatoprotective activities of aminoguanidine and N-acetylcysteine in rat against the toxic damage induced by azathioprine

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 134, Issue 4, 2003, Pages 451-456

  Raza, M ^a   Ahmad, M ^a   Gado, A ^a   Al Shabanah, O A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Aminoguanidine; Aminotransferases; Azathioprine; Glutathione; Hepatotoxicity; Lipidperoxides; N acetylcysteine; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; AMINOGUANIDINE; AMINOTRANSFERASE; AZATHIOPRINE; GLUTATHIONE; LIPID PEROXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; LIVER; LIVER CELL MEMBRANE; LIVER PROTECTION; LIVER TOXICITY; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037398812     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1532-0456(03)00022-X     Document Type: Article

References (32)

1. Aoki K., Ohmori M., Takimoto M., Ota H., Yashida T. Cocaine induced liver injury is mediated by nitric oxide and reactive oxygen species. Eur. J. Pharmacol. 336:1997;43-49.
2. Armstrong, V.W., Oellerich, M., 2001. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin. Biochem. 34(1), 9-16.
3. Arnott, I.D., Ghosh, S., 2000. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury. Eur. J. Gastroenterol. Hepatol. 12(5), 569-573.
4. Attri, S., Rana, S.V., Vaiphei, K., et al., 2000. Isoniazid- and rifampicin-induced oxidative hepatic injury - protection by N-acetylcysteine. Hum. Exp. Toxicol. 19(9), 517-522.
5. Corbett J.A., Tilton R.G., Chang K., et al. Aminoguanidine a novel inhibitor of nitric oxide formation prevents diabetic vascular dysfunction. Diabetes. 41:1992;552-556.
6. Courderot-Masuyer, C., Dalloz, F., Maupoil, V., Rochette, L., 1999. Antioxidant properties of aminoguanidine. Fundam. Clin. Pharmacol. 13(5), 535-540.
7. Cross A.H., Misko T.P., Lin R.F., Hikey N.F., Trotter J.L., Tilton R.G. Aminoguanidine an inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
8. Diez-Fernandez C., Sang N., Alvarez A.M., Zaragoza A., Cascales M. Influence of aminoguanidine on parameters of liver injury and regeneration induced in rat by a necrogenic dose of thioacetamide. Br. J. Pharmacol. 125:1998;102-108.
9. El-Khatib, S., Moustafa, A.M., Hamid, A.A., Al-Shabanah, O.A., El-Kashef, H.A., 2001. Effect of aminoguanidine and desferrioxamine on some vascular and biochemical changes associated with streptozotocin-induced hyperglycemia in rats. Pharmacol. Res. 43(3), 233-240.
10. Gardner C.R., Heck D.C., Yang C.S., et al. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology. 27:1998;748-754.
11. Gunnarsdottir, S., Elfarra, A.A., 1999. Glutathione-dependent metabolism of cis-3-(9H-purin-6-ylthio)acrylic acid to yield the chemotherapeutic drug 6-mercaptopurine: evidence for two distinct mechanisms in rats. J. Pharmacol. Exp. Ther. 290(3), 950-957.
12. Heneghan, M.A., McFarlane, I.G., 2002. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 35(1), 7-13.
13. Hobara, N., Watanabe, A., 1981. Impaired metabolism of azathioprine in carbon tetrachloride-injured rats. Hepatogastroenterology 28(4), 192-194.
14. Ihm S.H., Yoo H.J., Park S.W., Ihm J. Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats. Metabolism. 48:1999;1141-1145.
15. Jakus, V., Hrnciarova, M., Carsky, J., Krahulec, B., Rietbrock, N., 1999. Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity. Life Sci. 65(18-19), 1991-1993.
16. Lee, A.U., Farrell, G.C., 2001. Mechanism of azathioprine-induced injury to hepatocytes: roles of glutathione depletion and mitochondrial injury. J. Hepatol. 35(6), 756-764.
17. Mansoor, M., Daba, M.H., Gado, A., Al-Rikabi, A., Al-Majed, A., 2002. Protective effect of L-arginine against nephrotoxicity induced by cyclosporine in normal rats. Pharmacol. Res. 45(6), 441-446.
18. Matsumoto K., Sekita K., Ochiai T., et al. Evaluation of immunotoxicity testings using azathioprine-treated rats: the International Collaborative Immunotoxicity Study (Azathioprine). Eisei Shikenjo Hokoku. (108):1990;34-39. Article in Japanese.
19. McCay P.B., Gibson D.D., Fong K., Hornbrook K.R. Effect of glutathione peroxidase activity on lipid peroxidation in biological membranes. Biochem. Biophys. Acta. 431:1976;459-468.
20. Misko T.P., Moore W.M., Kasten T.P., et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 307:1993;287-293.
21. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
22. Ohkawa H., Ohishi N., Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric reaction. Anal. Biochem. 95:1979;351-358.
23. Prescott, L.F., Sutherland, G.R., Park, J., Smith, I.J., Proudfoot, A.T., 1976. Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet 17(2(7977)), 109-113.
24. Raza, M., Al-Bekairi, A.M., Ageel, A.M., Qureshi, S., 1997. Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: time dependence of peroxidative injury. Pharmacol. Res. 35(2), 153.
25. Read A.E., Wiesner R.H., La Brecque D.R., et al. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy. Ann. Intern. Med. 104:1986;651-655.
26. Sakaguchi, M., Furusawa, S., Yokota, K., Sasaki, K., Takayanagi, M., Takayanagi, Y., 2000. Effect of nitric oxide synthase inhibitors on lipid peroxide formation in liver caused by endotoxin challenge. Pharmacol. Toxicol. 86(4), 162-168.
27. Sedlak J., Lindsay R.H. Estimation of total, protein bound and nonprotein sulfhydryl groups in tissue with Elman's reagent. Analyt. Biochem. 25:1968;192-205.
28. Smith, C.C., Archer, G.E., Forster, E.J., Lambert, T.R., Rees, R.W., Lynch, A.M., 1999. Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaMouse. Environ. Mol. Mutagen. 34(2-3), 131-139.
29. Suzuki N., Sakamoto A., Ogawa R. Effect of L-canavanine, an inhibitor of inducible nitric oxide synthase on myocardial dysfunction during septic shock. J. Nippon Med. Sch. 69:2002;13-18.
30. Vale, J.A., Meredith, T.J., Goulding, R., 1981. Treatment of acetaminophen poisoning. The use of oral methionine. Arch. Intern. Med. 23;141 (3 Spec No), 394-396.
31. Wandel A. Glutathione peroxidase. Jakoby W.B. Enzymatic Basis of Detoxication, vol. 1. 1980;333-353 Academic Press, New York.
32. Weinbroum, A.A., Kluger, Y., Abraham, R.B., Shapira, I., Karchevski, E., Rudick, V., 2001. Lung preconditioning with N-acetyl-L-cysteine prevents reperfusion injury after liver no flow-reflow: a dose-response study. Transplantation 27(71(2)), 300-306.